Molecular Profile
What Is BPC-157?
TypeSynthetic pentadecapeptide
CAS Number137525-51-0
Molecular Weight1419.5 g/mol
Amino Acids15
SequenceGEPPPGKPADDAGLV
FormulaC62H98N16O22
⚠️ FOR RESEARCH PURPOSES ONLY — This compound is not FDA approved. All data presented is from clinical trials for educational reference.
Cellular Peptide
BPC-157
Body Protection Compound-157PL-14736PLD-116Bepecin
A 15-amino acid peptide derived from human gastric juice that demonstrates protection and regenerative effects in animal cell models. Premium Research Peptide.
Dosage
Quantity
1
$39.99
Dosage
Quantity
1
$39.99
Wed, Apr 29 - Tue, May 5
Overnight shipping available
We accept
BPC-157$39.99
Free shippingon orders over $150
Damageprotection
Secure checkout256-bit SSL
Certificate of Analysis
Third Party Tested by Freedom Diagnostics
Compound Information
Technical specifications
PubChem Database
Storage Requirements
Stability Information
Room temp stable (short-term)Protect from lightResist enzymatic degradation
Lyophilized (powder)
-20°C•stable
Reconstituted
2-8°C•use within 30 days
Gastric stability
24+ hours in gastric juice
Sources & References
Peer-reviewed research
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
2025•DOI: 10.1177/15563316251355551•PMID: 40756949
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
View Source
Journal of Applied PhysiologyThe promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
2011•DOI: 10.1152/japplphysiol.00945.2010•PMID: 21030672
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
View Source
Scientific Reports (Nature)Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
2020•DOI: 10.1038/s41598-020-74022-y•PMID: 33046803
Hsieh MJ, Lee CH, Chueh HY, et al.
View Source
Frontiers in PharmacologyPharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
2022•DOI: 10.3389/fphar.2022.1026182
He L, Feng D, Guo H, et al.
View Source
Regulatory Toxicology and PharmacologyPreclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds
2020•DOI: 10.1016/j.yrtph.2020.104665•PMID: 32334036
Xu C, Sun L, Ren F, et al.
View Source
Current NeuropharmacologyBrain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
2016•DOI: 10.2174/1570159x13666160502153022•PMID: 27138887
Sikiric P, Seiwerth S, Rucman R, et al.
View Source
Gut and LiverStable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection Revisited
2019•DOI: 10.5009/gnl18490
View Source
HSS JournalEmerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
2025•DOI: 10.1177/15563316251355551
Vasireddi N, Hahamyan H, Salata MJ, et al.
View Source
Pharmaceuticals (MDPI)Multifunctionality and Possible Medical Application of the BPC 157 Peptide
2025•DOI: 10.3390/ph18020185
Józwiak M, Bauer M, Kamysz W, Kleczkowska P
View Source
ClinicalTrials.govPCO-02 - Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
Neural Regeneration ResearchPentadecapeptide BPC 157 and the central nervous system
2022•DOI: 10.4103/1673-5374.320969•PMID: 34380875
Vukojevic J, Milavić M, Perović D, et al.
View Source
Journal of Molecular MedicineTherapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
2017•DOI: 10.1007/s00109-016-1488-y•PMID: 27847966
Hsieh MJ, Liu HT, Wang CN, et al.
View Source
Journal of Orthopaedic ResearchOsteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits
1999•PMID: 10071911
View Source
Alternative Therapies in Health and MedicineSafety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
2025•PMID: 40131143
Lee E, Walker C, Ayadi B
View Source
Growth Hormone & IGF ResearchBPC-157 enhances growth hormone receptor expression in injured tendon tissue
2018•DOI: 10.1016/j.ghir.2018.02.001
Staresinic M, Sebecic B, et al.
View Source
Multiple Sources (Meta-analysis)BPC-157 healing timeline observations from preclinical studies
2024
View Source
⚠️Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
All clinical trial data and research findings presented on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.
